Calla Lily Starts FREEDOM Trial for Callavid Platform
LONDON, United Kingdom – May 6, 2026 Calla Lily Clinical Care has announced dosing of the first patients in...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 Clinical Trial Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
LONDON, United Kingdom – May 6, 2026 Calla Lily Clinical Care has announced dosing of the first patients in...
BASEL, Switzerland and BOSTON, MA, May 1, 2026 Noema Pharma AG announced the presentation of positive Phase 2a clinical...
Pittsburgh, USA | May 1, 2026 Viatris has announced multiple clinical data presentations for its investigational low-dose estrogen combined...
New York, USA – April 22, 2026 Utepreva announced the launch of its FDA 510(k)-cleared Endometrial Sampler, an innovative...
ELMWOOD PARK, New Jersey, April 9, 2026 Glenmark Pharmaceuticals Limited has received final approval from the U.S. Food and...
MILFORD, Mass., April 8, 2026 Waters Corporation has announced U.S. FDA clearance for its Onclarity™ HPV Self-Collection Kit, enabling...
MOUNTAIN LAKES, NEW JERSEY, USA | March 24, 2026 LiviWell, a women’s health innovation company, has announced U.S. FDA...
AMSTERDAM, Netherlands — November 27, 2025. Arletta Pharma Solutions, formerly known as Freya Pharma Solutions, has unveiled a major...
SAN DIEGO, Oct. 1, 2025 — Evofem Biosciences announced that its Middle East partner has submitted an application to...
Berlin, Germany – September 19, 2025 — Bayer announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...
